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Abstract
Protein-based therapeutics feature large interacting surfaces. Protein folding endows structural stability to localised surface
epitopes, imparting high affinity and target specificity upon interactions with binding partners. However, short synthetic
peptides with sequences corresponding to such protein epitopes are unstructured in water and promiscuously bind to
proteins with low affinity and specificity. Here we combine structural stability and target specificity of proteins, with low
cost and rapid synthesis of small molecules, towards meeting the significant challenge of binding coiled coil proteins in
transcriptional regulation. By iteratively truncating a Jun-based peptide from 37 to 22 residues, strategically incorporating
iRi+4 helix-inducing constraints, and positioning unnatural amino acids, we have produced short, water-stable, a-helical
peptides that bind cFos. A three-dimensional NMR-derived structure for one peptide (24) confirmed a highly stable a-helix
which was resistant to proteolytic degradation in serum. These short structured peptides are entropically pre-organized for
binding with high affinity and specificity to cFos, a key component of the oncogenic transcriptional regulator Activator
Protein-1 (AP-1). They competitively antagonized the cJun–cFos coiled-coil interaction. Truncating a Jun-based peptide
from 37 to 22 residues decreased the binding enthalpy for cJun by ,9 kcal/mol, but this was compensated by increased
conformational entropy (TDS #7.5 kcal/mol). This study demonstrates that rational design of short peptides constrained by
a-helical cyclic pentapeptide modules is able to retain parental high helicity, as well as high affinity and specificity for cFos.
These are important steps towards small antagonists of the cJun-cFos interaction that mediates gene transcription in cancer
and inflammatory diseases.
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Introduction
Cellular functions are mediated by protein-protein interactions,
the majority involving large interacting surface areas with binding
interfaces that are shallow, hydrophilic and lack the well-defined
small hydrophobic clefts that are most tractable for design of small
molecule inhibitors. Driven by the need to target these larger
protein surfaces, there has been renewed interest in recent years in
developing larger therapeutic molecules, such as peptides and their
mimetics, which can in principle combine advantages of proteins
(target specificity, structural stability) with advantages of small
molecules (lower cost, oral activity) [1]. One approach is to
engineer small synthetic components of protein surfaces (‘protein
surface mimetics’) [2] to compete for (antagonists) or mimic
(agonists) protein-protein interactions that mediate disease. How-
ever, peptides have also traditionally been perceived as being
problematic therapeutics as they are often considered too large,
too polar and too susceptible to protease degradation in order to
traverse intact across biological membranes. Conjugating small (5–
12 residue) protein-transduction domains or arginine-rich pep-
tides, such as TAT and antennapedia fragments [3,4,5] to peptide
cargo can be used to facilitate cell penetration. However, those
sequences increase peptide size and are themselves susceptible to
proteolytic degradation. Rendering peptides protease resistant has
been more difficult to engineer without replacing key components
with non-peptidic groups, or creating N- to C-terminal ‘cyclic
peptides’, to bring stability and bioavailability to the peptide (see
[1,2,3] and references therein). More recently, constraints have
been incorporated into peptide sequences to induce bioactive
helix, strand or turn structural motifs that have high affinity for
receptors without the need for larger sequences [6,7,8,9,10,11].
Alpha helices have been successfully stabilized by introducing
constraints in the side-chains of amino acids
[12,13,14,15,16,17,18,19] or within the peptide backbone using
hydrogen bond surrogate approaches
[20,21,22,23,24,25,26,27,28,29,30]. In the HBS approach a-
helices feature a carbon2carbon bond in place of an N-terminal
intramolecular hydrogen bond between the peptides i and i +4
residues. Thus organizing three consecutive amino acids into the
helical orientation inherently limits the stability of short a-helices.
The HBS method affords preorganized a-turns to overcome this
intrinsic nucleation barrier and initiate helix formation.Other
approaches include b-peptides [31,32], without interfering with
the helix surface designed to interact with the target protein,
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thereby conferring high helicity that confers protein-like function
upon peptides that would otherwise have low or negligible
biological potency. We have previously used one-turn (iRi+4)
rather than two-turn (iRi+7) bridging constraints to induce a-
helicity [9,11,33,34], since our research supports greater per
residue helicity even though this is contrary to polymer theory
[35]. The approach can however be context dependent, and
requires extensive further investigation to realise its promise.
The Jun-Fos Activator Protein-1 (AP-1), is a helical heterodimer
and oncogenic transcriptional regulator implicated in a range of
diseases that includes cancer [36,37,38], bone disease (e.g.
osteoporosis) and inflammatory diseases such as rheumatoid
arthritis and psoriasis [39,40,41]. A number of intracellular
signalling cascades converge at AP-1, producing changes in gene
expression profiles that can cause tumour formation, progression
and metastasis. Here we begin with a 37 residue peptide
(JunWCANDI) found to bind specifically to cFos in the presence
of cJun [42] by binding to the coiled coil region that is responsible
for driving AP-1 heterodimerization. In brief, the coiled coil is
characterised by a repeat of seven amino acids, denoted a-g;
residues a and d consist largely of hydrophobic residues, forming a
stripe which associates with respective partners on the other helix.
Core flanking charged residues at e and g positions form
interhelical ion pairs with g and e_residues in the neighbouring
helix and aid heterospecificity [43]. Core region proximity means
these residues are also partially shielded from the solvent [44].
Since the Jun-Fos dimer interface is responsible for mediating key
transcriptional events associated with disease induction, it may be
a worthy target for therapeutic intervention. We have previously
reported peptides of 33–37 amino acids, based on the coiled coil
region known to control dimerization [45,46], and flanked by N-
and C-terminal capping motifs, that were able to bind and
sequester either cJun or cFos to prevent Jun-Fos heterodimer
formation, initiation of gene transcription, and cell differentiation
and proliferation [42,47,48,49]. These peptides were however too
large to be useful therapeutics. By systematically truncating the 37
residue peptide ‘JunWCANDI’ [42], together with strategic intro-
duction of helix constraints (Figure 1), we sought to establish (i)
whether helix-constrained peptides could be significantly reduced
in length while maintaining effective binding; (ii) whether the
downsized peptides maintained high binding specificity for cFos
relative to cJun; (iii) whether there was a key consensus region
within the coiled coil that was essential for binding; and (iv)
whether the approach required mainly enthalpic or entropic
contributions to be successful. The latter is important because
coiled coils typically require interactions along their entire lengths
for structural stability.
We report that a-helical cyclic pentapeptide modules inserted
into truncated sequences from within the JunWCANDI peptide
results in much shorter water-stable a-helical peptides that retain
the high affinity and specificity of the parental JunWCANDI peptide
for cFos, and are stable to proteolytic degradation. Affinity for
cFos is driven by a combination of interactions along most of the
sequence of cJun, and we were able to pinpoint key co-facial
residues that contribute to the overriding enthalpic properties that
dictate peptide potency. This is an important step forward in
understanding how to rationally design small transcriptional
regulators.
Experimental Procedures
Peptide Synthesis and Purification
Peptide synthesis was performed as described [9,11,33] by Fmoc
chemistry. The phenyl isopropyl ester of aspartic acid and methyl
trityl group of lysine were removed from the peptide-resin with 3%
TFA in dichloromethane (DCM) (562 min). Cyclization was
effected on-resin using Benzotriazole-1-yl-oxytris-(dimethylamino)-
phosphonium hexafluorophosphate (BOP) and 1-hydroxy-7-aza-
benzotriazole (HOAt), base N,N-Diisopropylethyamine (DIPEA),
and DMF (1A1). The procedure was repeated for multiple
cyclizations. Crude peptides were purified by rp-HPLC (Rt1:
Vydac C18 column, 300 A˚. 226250 mm, 214 nm, Solvent
A = 0.1% TFA in H2O, Solvent B = 0.1% TFA, 10% H2O in
acetonitrile. Gradient: 0% B to 70% B over 35 min). Peptides were
.95% purity by analytical HPLC. Correct masses were verified
by electrospray mass spectrometry. Peptide masses were as follows:
cFos = 4147; 1= 3747; 2= 3740; 3= 3792; 4= 3791; 5= 2208;
6= 2201; 7= 2183; 8= 2926; 9= 2951; 10= 2661; 11= 2675;
12= 2668; 13= 2291; 15= 2287; 16= 2751; 17= 2701;
18= 2786; 19= 2730; 20= 2730; 21= 2675; 22= 2704;
23= 2661; 24= 2751. All synthetic peptides were N- acetylated
and C-amidated. Peptide concentrations were determined by dry
weight and verified via absorbance in water at 280 nm with an
extinction coefficient of 1209 M21 cm21 [50] corresponding to a
single Tyr residue inserted into a solvent-exposed b3 heptad
position. The peptide concentration for 2, 6 and 7 were
determined by dry weight alone since the b3 Tyr was replaced
by an Lys residue that formed part of the helix constrained
peptide.
NMR Spectroscopy
A sample for NMR analysis (Figure 2) was prepared by
dissolving peptide 24 (2.0 mg) in 540 mL H2O and 60 mL D2O.
1D (variable temperature experiments) and 2D 1H-NMR spectra
were recorded on a Bruker Avance 600 and 900 MHz spectrom-
eters respectively. 2D 1H-spectra were recorded in phase-sensitive
mode using time-proportional phase incrementation for quadra-
ture detection in the t1 dimension. 2D experiments included
TOCSY (standard Bruker mlevgpph pulse program) and NOESY
(standard Bruker noesygpph pulse program) and dqf-COSY
(standard Bruker dqfcosygpph pulse program). TOCSY spectra
were acquired over 9920 Hz with 4096 complex data points in F2,
256 increments in F1 and 32 scans per increment. NOESY spectra
were acquired over 9920 Hz with 4096 complex data points in F2,
512 increments in F1 and 32 scans per increment. TOCSY and
NOESY spectra were acquired with several isotropic mixing times
of 80 ms for TOCSY and 200–250 ms for NOESY. For all water
suppression was achieved using modified WATERGATE and
excitation sculpting sequences. For 1D 1H NMR spectra acquired
in H2O/D2O (9:1), the water resonance was suppressed by low
power irradiation during the relaxation delay (1.5 to 3.0 s).
Spectra were processed using Topspin (Bruker, Germany) software
and NOE intensities were collected manually. The t1 dimensions
of all 2D spectra were zero-filled to 1024 real data points with 90u
phase-shifted QSINE bell window functions applied in both
dimensions followed by Fourier transformation and fifth order
polynomial baseline correction. Variable temperature NMR
experiments were performed over 278–318 K. 1H chemical shifts
were referenced to DSS (d 0.00 ppm) in water. 3JNHCHa coupling
constants were measured from 1D 1H NMR and dqf-COSY
spectra. The assigned 1H NMR signals for peptide 24 can be
found in Table S2.
Structure Calculations
The distance restraints used in calculating a solution structure
for 24 in water was derived from NOESY spectra recorded at
298 K or 288 K by using mixing time of 250 ms. NOE cross-peak
volumes were classified manually as strong (upper distance
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constraint # 2.7 A˚), medium (# 3.5 A˚), weak (# 5.0 A˚) and very
weak (# 6.0 A˚) and standard pseudo-atom distance corrections
were applied for non-stereospecifically assigned protons. To
address the possibility of conformational averaging, intensities
were classified conservatively and only upper distance limits were
included in the calculations to allow the largest possible number of
conformers to fit the experimental data. Backbone dihedral angle
restraints were inferred from 3JNHCHa coupling constants in 1D
spectra, w was restrained to –60630u for 3JNHCHa # 6 Hz.
Starting structures with randomized w and y angles and extended
side chains were generated using an ab initio simulated annealing
protocol. The calculations were performed using the standard
force field parameter set (PARALLHDG5.2.PRO) and topology
file (TOPALLHDG5.2.PRO) in XPLOR-NIH with in house
modifications to generated iRi+4 helix constraints between lysine
and aspartic acid residues and unnatural amino acid Cyclohex-
ylalanine (Cha). Refinement of structures was achieved using the
conjugate gradient Powell algorithm with 2000 cycles of energy
minimization and a refined force field based on the program
CHARMm [51]. Structures were visualized with Pymol and
analyzed for distance (.0.2 A˚) and dihedral angle (.5u) violations
using noe.inp and noe2emin.inp files (in Xplor). Final structures
contained no distance violations (.0.2 A˚) or angle violations
(.5u). Corresponding NMR coordinates are available upon
request.
Serum Stability
Stock solutions of 12 and 24 in both constrained forms and
linear forms lacking constraints were prepared in water (1 mg/ml),
200 mL was added to human serum (800 mL) and incubated at
37uC. Aliquots (100 mL) of this diluted serum were removed at 0,
0.5, 1, 2, 4, 16, and 24 hours and a mixture of acetonitrile/water
3:1 (300 mL) was added to each aliquot before centrifuging
(17000 rpm, 15 min). Aliquots (100 mL) of the supernatant were
then analysed by LC-MS-MS after passing through a
2.16150 mm Phenomenex 300A C18 5 mm column at 10% per
minute linear gradient from 0–100% acetonitrile over 12 minutes.
The amount of starting material was quantified by determination
of total ion counts for the m/3+ and m/4+ ion for each peptide
(Figure 3).
Figure 1. Schematic showing sequences and constrains for all peptides. The parental JunWCANDI sequence is shown in bold as are heptads
and residue positioning within the helical wheels. Peptide constraints are shown in blue. KD values taken from ITC experiments for peptides in
complex with cFos are shown in mM. Fraction helicity as measured from CD experiments are also shown. Positions of iRi+4 hydrocarbon constraints
were initially placed into a JunWCANDI peptide [42] lacking capping motifs, causing a reduction in the size of the molecule from 37 residues to 32. All
constraints tethered bRf or fRc residues.
doi:10.1371/journal.pone.0059415.g001
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Circular Dichroism
Circular dichroism (CD) spectroscopy was conducted with an
Applied Photophysics Chirascan CD spectroploarimeter (Leather-
head, U.K.) using a 200 mL sample in a CD cell with a 1 mm path
length (Hellma, Mu¨llheim Germany). Samples contained 150 mM
total peptide concentration suspended in 10 mM potassium
phosphate and 100 mM potassium fluoride at pH 7. The CD
spectra of the homodimeric and heterodimeric complexes were
scanned between 300 nm and 190 nm at 20uC (for both pre- and
post-melt samples to check for reversibility of unfolding) and at
28uC to assess helical levels and coiled-coil structure (see Figure 4).
All data have been converted from raw ellipticity to molar residue
ellipticity according to the equation:
MRE~
h
10|l|r|c
ð1Þ
Where h is the CD signal of the sample in millidegrees, l is the
pathlength of the cell in centimetres, r is the number of residues in
the peptide, and c is the total peptide molar concentration of the
sample.
Thermal Melts
Spectra and thermal melts were performed on 150 mM
peptides in 10 mM potassium phosphate, 100 mM potassium
fluoride, pH 7, using an Applied Photophysics Chirascan CD
instrument (Leatherhead, U.K.). The temperature ramp was set
to stepping mode using 1uC increments and paused for 30
seconds at each temperature before measuring ellipticity at
222 nm. For all temperature denaturation experiments data
collection was started at 28uC, and at this temperature the
peptide solutions remained aqueous. Data points for thermal
denaturation profiles represent the averaged signal after 4 s of
data collection. Samples were identical in composition to the
CD buffer samples. Melting profiles (see Figure 4) were $95%
reversible with equilibrium denaturation curves fitted to a two-
Figure 2. NMR Structure of peptide 24. a) NOE summary diagram for peptide 24 in 90% H2O:10% D2O at 298 K. Sequential, short and medium
range NOE intensities were classified as strong (upper distance constraint 2.7 A˚), medium (3.5 A˚), weak (5.0 A˚), very weak (6.0 A˚) and are proportional
to bar thickness; grey bars indicate overlapping signals. 3JNHCHacoupling constants ,6 Hz are indicated byQ. Amide NH’s for which chemical shifts
changed by ,5 ppb/K are indicated by N. b) Backbone superimposition for ten lowest energy NMR-derived solution structures for Ac-cyclo-(3,7;
10,14; 17,21)-ChaR[KEIYD]LR[KKAND]LR[KHIAD]Cha-NH2 (24) in H2O:D2O (9:1) at 298 K showing carbon atoms (green), nitrogens (blue), oxygens (red),
iRi+4 hydrocarbon constraints (orange). Also for clarity, one structure is shown with its alpha helical backbone (yellow) and projecting side chains
(green). N-terminus is at the top.
doi:10.1371/journal.pone.0059415.g002
Figure 3. Serum stability of peptides 12 and 24. Shown are the
effects of helix-inducing constraints (N and &) versus the linear
sequences (. and m) in human serum at 37uC.
doi:10.1371/journal.pone.0059415.g003
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state model (see [52]) to yield the melting temperature (Tm):
DG~DH{ TA=Tmð Þ| DHzR|Tm| ln Ptð Þð Þ
zDCp| TA{Tm{TA| ln TA=Tmð Þð Þ
ð2Þ
where DH is the change in enthalpy, TA is the reference
temperature in Kelvin; R is the ideal gas constant (1.9872 cal?-
mol–1?K–1); Pt the total peptide concentration (150 mM); and
DCp the change in heat capacity [47]. Helix heterodimerisation
is inferred in cases where melting profiles for heterodimers are
clearly distinct from averages of constituent homodimeric melts
(Shown in Figure 4 and via dimer exchange in Figure S3). The
cooperative nature of the melting profiles suggests an apparent
two-state process. Tm values were determined by least-squares
fitting of the denaturation assuming a two-state folding model
that is widely used for coiled coils and provided an excellent fit
to our data.
Inspection of Homo and Heterotypic CD Data
Thermal denaturation data and spectra for the cFos homotypic
complex (black), helix constrained peptide (blue), and heteromeric
complex (red) were recorded using 200 mL of sample at 150mM
total peptide concentration (Figure 4, Figure S1). Next, 100 mL of
each solution was mixed and the spectra taken such that the final
total peptide concentration was also 150 mM. More experimental
procedures can be found in File S1.
Figure 4. Raw thermal melting data for all homo and heterodimeric complexes. Data have been collected by measuring the level of helicity
at 222 nm in an applied photophysics chirascan Circular Dichroism (CD) Spectrometer. Data have been converted from raw ellipticity to Molar
Residue Ellipticity (MRE) according to equation 1 to take account of the different peptide lengths. Thermal melting data for cFos is shown in black,
data for the constrained peptide in isolation is shown in blue and the cFos/constrained peptide mixture is shown in red. Also shown is the average of
the cFos and constrained peptide (black dotted line). Where possible data have been fitted to equation 2 to generate thermal melting (Tm) values
(e.g. for cFos-1 and cFos-2) and in such instances it is clear from an increase in the averaged homomeric Tm values that an interaction is occurring (e.g.
1: 21+50 = 49/2 = 24.5,55). However, some data were unable to be fitted owing to the lack of a melting transition, or of a lower baseline (e.g. cFos-3
and cFos-4), indicating that an interaction is not occurring. CD spectra for these pairs are given in Figure S3.
doi:10.1371/journal.pone.0059415.g004
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Results
Design Rational and Evolution of the Helix-constrained
Peptide Sequences
Our first aim was to systematically introduce helix-inducing
constraints into JunWCANDI which has been shown to be specific
for cFos in the presence of cJun [42]. All helix-constrained
peptides lack five residues that served as N-terminal and C-
terminal capping motifs in the JunWCANDI parent peptide
[42,47,48]. This led us to examine the effect on helix induction
of one or more such constraints placed at different positions within
the sequence, while concomitantly truncating the sequence from
either terminus. The goal was to decrease the peptide length while
maintaining the peptide helicity using one or more helix-inducing
constraints. The process was iterative, generating 24 peptides. We
find that introduction of helical constraints leads to a stable
heterodimeric peptide with cFos for some but not all of the
constructs developed, indicating that induction of helicity alone is
insufficient to achieve binding:
Peptides 1–4
Our initial series of four constructs (Figure 1) were based on the
JunWCANDI scaffold (4.5 heptads in length), but lacked the N- and
C-terminal capping motifs. Thus at 32 residues these peptides
were five residues shorter than this ‘Protein-fragment complementation
assay’ (PCA) derived parent peptide [42,47,48], but retained all
regions of the coiled coil. The first four peptides synthesized (1–4,
Figure 1) each had one iRi+4 helix constraint formed by inserting
Lys and Asp in place of solvent exposed residues between positions
b and f in one of the four heptads of the coiled coil. Circular
dichroism spectra were used to measure the relative extent of a-
helix induction and showed that we were successful in our design
process (Table S1, Figure S1). Constraints in either of the two C-
terminal heptads were more effective than in the two N-terminal
heptads at inducing a-helicity (1, 63%; 2, 30%; 3, 14%; 4, 15%;
Table S1), suggesting an important effect of the sequence
environment surrounding the constraint which was most helix-
inducing when placed in the most C-terminal heptad (e.g. 1). This
led to two peptides that bound (1 and 2– constrained at the C-
terminal end of the molecule; see Figure 1) and two that did not (3
and 4– constrained at the N-terminal end). Our interpretation of
this result was that the first two heptads are less important in
binding cFos and that the latter two heptads were crucial. Indeed,
cFos-1 displays a Tm of 55uC; 11uC higher than the cFos-
JunWCANDI [42], while cFos-2 displays a Tm of 53uC, amounting
to KD values of approximately 1 mM as verified by ITC (see
Table 1). In contrast, cFos-3 and cFos-4 did not generate a
thermal denaturation profile that could be fitted to equation 2;
rather the profile lacked a lower baseline and entered partway
through the unfolding transition (see Figure 4). The data also
shows that 3 or 4 in solution with cFos results in much lower
helicity than cFos with 1 or 2 (cFos-1, 65%; cFos-2, 39%),
compared to 3 or 4 (cFos-3, 17%; cFos-4, 26%). For this reason,
thermal denaturation data could only be fitted and normalised to a
fraction unfolded where satisfactory denaturation profiles, lower
baselines and overall fit to equation 2 could be attained. We
interpreted cFos-1 stability as being attributable to helical
propensity resulting from a constraint at the C-terminus, where
less helical structure in the parent protein might be assumed. The
same outcome is not observed for the N-terminal constrained
peptides 3 and 4, which are significantly less helical. We therefore
inferred that the N-terminal region does not play a substantial role
in binding, or that these constraints cause steric interference at this
end of the molecule. All of these peptides retained ten core a/d
residues per helix for hydrophobic interactions and six electrostatic
e/g interactions (Figure 1).
Table 1. Thermodynamics of binding of cJun analogues to cFos. Columns (from left to right) show i) Tm values from thermal
denaturation analysis ii) calculated % helicity for each respective pair calculated from circular dichroism spectra and iii) KD values
calculated from thermal denaturation data.
Peptide complex Tm 6C % Helical
KD(20) (Thermal)
mM *KD(20) M
21 (ITC) mM N
DG(20) kcal/
mol (ITC)
DH kcal/
mol
#TDS kcal/mol [DH
– DG]
cFos-cFos 21 20% 325 N/D N/D N/D N/D N/D
cFos-JunWCANDI 44 42% 0.45 1.260.05 0.860.01 27.960.03 214.860.3 26.960.3
cFos-1 55 65% 0.50 0.3960.03 0.860.01 28.660.04 211.660.1 23.060.1
cFos-2 53 39% 0.19 1.4460.09 1.260.01 27.860.04 27.160.1 +0.760.1
cFos-8 32 38% 21.5 55612.45 1.060.35 25.760.13 29.560.4 23.860.4
cFos-9 38 47% 9.2 N/A N/A N/A N/A N/A
cFos-10 49 52% 1.7 5.860.78 0.860.01 27.060.08 28.460.9 21.460.9
cFos-11 47 55% 5.8 5.460.28 0.760.01 27.060.03 27.760.2 20.760.2
cFos-12 52 40% 1.2 7.660.51 1.060.02 26.860.04 26.160.2 0.760.2
cFos-17 44 40% 7.8 11.460.88 1.060.03 26.66.0.05 25.460.3 1.260.3
cFos-20 48 49% 3.8 11.260.82 1.160.03 26.660.04 27.560.3 20.960.3
cFos-22 51 40% 1.4 11.961.16 1.460.04 26.660.06 25.060.2 1.660.2
cFos-24 58 52% 7.2 7.2560.64 1.160.03 26.960.05 28.860.4 21.960.4
The remaining three columns give stoichiometry of binding and thermodynamic data calculated from ITC, with TDS calculated according to the Gibbs Helmholtz
equation.
*data calculated using the midpoint of the transition from thermal denaturation profiles (and fit as temperature as a function of lnKD, with the fit lnKD = aT+C where a is
the gradient, T is the temperature in Celsius and C is the intercept) and calculated at 20uC.
#Calculated according to TDS =DH2DG.
doi:10.1371/journal.pone.0059415.t001
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Peptides 5–7
Using data from the first four peptides, our next group of
synthetic constrained peptides were synthesized. These were
truncated by two heptads at the N-terminus of the peptide
(ND14, 18 residues) and a single (5 and 6) or double (bicyclic –7)
constraint introduced. Much shorter peptides 5 and 6 had a single
helix constraint but were not much more helical (34% and 30%)
than the expected statistical ratio of just making 5 of the 18
residues (27%) helical due to their presence in the cyclic
pentapeptide component, while there was no additive effect of
combining both helix-inducing constraints within the same
sequence (e.g. as for peptide 8). Unfortunately, none of these
peptides resulted in a stable interaction with cFos. Again, no lower
baseline for thermal denaturation profiles was observed and
therefore no fit could be given in estimation of the Tm (see Figure 4
for raw data). The MRE at h222 was approximately 212000 at
20uC, indicating a comparatively low level of helicity ([26–29%
helical], Table S1) compared to cFos-1 or cFos-2. In addition,
peptides 5–7 were all more helical in isolation than as heteromeric
mixtures with cFos, with all transitions unable to produce a
thermal denaturation profile indicative of a stable interaction.
Peptides 5–7 had six core residues per helix for hydrophobic
interaction (four less than peptides 1–4) and only three electro-
static e/g interactions (three less than peptides 1–4), which may
account for the loss in activity.
Peptides 8–11
Data taken from peptides 1–7 was used in the design of four
further peptides 8–11 (Figure 1). In this group, 8 contained the
same sequence as 1 but with an additional seven residues
truncated from the C-terminus (CD7, 25 residues). The constraint
also resides closer to the C-terminus of the molecule relative to 1.
The bi-cyclic 9 contained the same sequence and constraint as 8
but with the additional N-terminal constraint found in the
unsuccessful peptide 4; its insertion resulted in a modest helicity
gain over 8 (h222 at 20uC =221000 versus. 214000). The logic
behind this was that by constraining both the N-and C-terminus of
the peptide, helicity would be propagated and maintained across
the entire molecule. Interestingly, cFos-8 (which contains one fRc
constraint, 32uC) performed comparably to cFos-9 (one N-
terminal bRf constraint and one C-terminal fRc constraint, Tm
38uC), indicating that the inclusion of the N-terminal constraint in
this bicyclic peptide had only a modest influence on the interaction
stability. Taken together with data for 4, this reinforces the
argument that inclusion/constraint of this N-terminal region is less
important for interaction with cFos. The heterodimeric stability
for these two peptides was almost 20uC less than for cFos-1 or
cFos-2, therefore indicating that at least part of the CD7 deletion is
an important binding determinant. Given the low affinity of the N-
terminally truncated constrained peptides 5–7 for cFos, and the
modest binding affinity afforded by peptides 8–9, two bi-cyclic
peptides 10 and 11 were created to make less severe N-terminal
truncations than peptides 5–7 (ND10 versus ND14, see Figure 1).
Importantly, this more modest truncation incorporated the
hydrophobic ‘d’ residue of the second heptad with the constraint
inserted in close proximity, ensuring that the helical integrity of
this region was maintained entirely to the helical termini. In
addition, 10 and 11 retained the complete C-terminal region with
a second constraint either close to (11) or at (10) the C-terminus.
10 contains an f2Rc3 and an f4Rc5 constraint whereas peptide 11
contains an f2Rc3 and a b4Rf4 constraint. These peptides
increased the Tm with cFos by 9–17uC relative to peptides 8–9,
and within 4–8uC of peptides 1 and 2 (and with comparable levels
of helicity) despite being 10 residues shorter. Reassuringly,
peptides 8–11 all give thermal denaturation profiles that can be
fit by equation 2. It is also worth noting that although the position
of the constraint is always between bRf or fRc (and therefore
always tethers iRi+4 and is positioned away from the a/d/e/g
residues associated with the dimeric coiled coil interface), it cannot
be ruled out that the precise position of the constraint, and the
residues that become replaced by the Lys-Asp pair, do not affect
binding affinity in the resulting peptide. In addition, although
some peptides are very helical in isolation (as would be expected
for such conformationally restricted chains), others exhibit no
unfolding transition upon thermal melting, with interaction clearly
observed via a cooperative unfolding transition upon mixing with
cFos. Lastly, peptides 8–11 had eight (for 8–9) or seven (for 10–11)
core residues per helix for hydrophobic interaction (two or three
respectively less than for 1–4) and five electrostatic e/g
interactions (one less than 1–4). Despite the fact that more core
residues are present in 8–9, more stability is observed for cFos in
complex with 10–11, indicating that reduced core packing is
compensated for in these constrained variants. From 9 onward, all
peptides contained two or three helix-inducing constraints, with
only the 25-mer 9 (52%), and 22-mers 10 (57%), 11 (63%), 20
(51%) and 24 (69%) displaying about twice the helicity of peptides
5–8 (30–35%).
Peptides 12–17
Based on the above findings, six constrained peptide variants
were synthesised: 12–17. 12 contained the three combined
constraints of peptides 9 and 10 based on the scaffold of 10 and
produced a comparable Tm of 52uC. 13 was the same as 11 but
truncated by four residues from the C-terminus, and resulting in
severely diminished binding and helicity. 15 was truncated by the
same four residues as 13 with a similar bi-cyclic constraint; it was
also unsuccessful and similarly displayed reduced helicity and poor
thermal denaturation profile. 16 was identical to 11 with an a4
changed from Ala to Phe. This was due to a hydrophobic pocket in
the crystal structure that was anticipated to be occupied by the
exchange, but this design was also unsuccessful. 17 was also based
on 11 with the d3 Leu changed to Cyclohexylalanine (Cha) as an
alternative attempt to add hydrophobic bulk to the core in this
central region. In particular, we wanted to increase the
hydrophobicity in this part of the leucine zipper, since both 13
and 15 had failed in being truncated by four Leu residues relative
to 11. 12 and 17 both represent ND10 truncations relative to
JunWCANDI and maintains seven of ten a/d core residues and five
of six electrostatic e/g interactions.
Peptides 18–24
From the success of 12 and 17 in the previous cohort, six further
peptides were synthesised; all contained the same f2Rc3 and
b4Rf4 constraint. 18 contained four Cha sidechains – one at each
d position (see Figure 1). 19 contained two Cha residues at the
central two d positions of the same template, with 20 containing
two Cha residues at the outermost d positions of the same
template. The final three peptides were identical to 11 but
contained point mutations; IleRAsn at a3 to provide a partner for
a3 Lys in cFos, LysRArg at e2 to provide an enhanced
electrostatic contact with a g’1 Glu in cFos, and a LysRLeu at
g3 for a potentially enhanced hydrophobic effect with e’4 Leu in
cFos. These changes were made in 21–23 respectively. Of these
six, only 20 and 22 gave profiles consistent with a strong
interaction affinity for cFos. For 20, placement of bulky
hydrophobic groups at the outermost d positions helps to stabilise
the dimer, possibly by also helping to constrain the helix to its
target and aid in maintaining overall helicity. For 22 enhancing
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this electrostatic interaction would be predicted to add around
0.3 kcal/mol of stability [53], but clearly makes a large difference
since 21 has a much lower affinity. Lastly, peptide 24 was
synthesized to incorporate all of the changes introduced into 12,
20, and 22 - the three shortest and most effective peptides studied.
This, the most helical peptide, was fifteen residues shorter than the
JunWCANDI parent peptide, ten residues shorter from the N-
terminus than peptide 1, and more helical than both (Figure 1).
Indeed, 24 was three and a half times more helical than
JunWCANDI (69% vs 19%) based on CD spectra. Lastly,
conventional substitutions were made, as well as substituting
leucine with the bulkier unnatural amino acid cyclohexylalanine
(Cha) in 17–20 and 24 to increase both hydrophobicity and
potentially the core packing in this part of the coiled coil.
Unnatural amino acids at the ends of a peptide can potentially
confer proteolytic stability to degradation by carboxy- or amino-
peptidases. The CD data for peptides 17–24 suggest that
placement of Cha groups at the temini enhances helicity. The
two triply bridged peptides 12 (43%) and 24 (69%) differed only in
the N-terminal Leu-Lys and C-terminal Leu in 12 being replaced
by Cha-Arg and Cha respectively in 24. The Cha residues
contribute to this helix increase (cf. 20, 51% vs. 12, 43%) but there
is an even larger helix induction through the Lys to Arg change
(20 vs 24).
Binding Affinity of Helix-constrained Peptides for cFos
Having identified a number of peptides able to adopt highly
helical conformations upon introduction of the constraint, we
sought to measure their binding affinities for cFos and explore
relationships between affinity and helicity. Peptides 1, 2, 8, 9, 10,
11, 12, 17, 20, 22, and 24 are compared in Figure 4 for their
capacity to interact with cFos based on thermal denaturation
experiments. Although there was no quantitative linear correlation
between peptide helicity and affinity for cFos, there was a
qualitative relationship. No peptides with ,30% helicity were able
to form a stable interaction with cFos and most peptides with high
helicity also had high affinity for cFos, the mean helicity of
interacting peptides being 49% versus 32% for non-interacting
peptides. Despite truncating 15 residues from JunWCANDI (.40%
of all residues) and 10 residues from 1 (.30% of the molecule),
peptide 24 had the highest Tm of 58uC. Similarly, most of the
more helical peptides (e.g. 1, 2, 10, 11, 12, 20, 22) had a Tm
around 50uC, resulting in KD values of ,1–11 mM for binding to
cFos (Table 1).
In addition to thermal denaturation profiles, isothermal
calorimetric data could be obtained for all but one of the peptides
in complex with cFos. To verify interactions between constrained
peptides and cFos, we compared spectra for cFos alone,
constrained peptide alone, and for the mixture of the two (Figure
S1). For certain cFos-constrained peptide mixtures (e.g. ,30%
helicity), the observed spectra matched the average of the previous
two spectra, indicating that no exchange of dimer had occurred.
For some mixtures of cFos with a constrained peptide, the
observed signal from the spectra exceeded that of the averaged
homodimeric spectra, indicating binding. All peptides that
perfomed well in thermal denaturation studies generated spectra
that exceeded the average of component homodimers.
Specificity of Helix-constrained Peptides for cFos
To establish if the truncated and constrained peptides retained
the interaction specificity of the JunWCANDI parent peptide,
peptides capable of interacting with cFos were also incubated at
equimolar concentrations with cJun and monitored via CD
spectra. In addition, thermal denaturation was used to establish
if an interaction took place, and therefore if the specificity
exhibited by the JunWCANDI parent was retained for constrained
and truncated sequences. None of the peptides capable of forming
an interaction with cFos were found to interact with cJun in these
experiments (Figures S2, S3, S4), indicating specificity of the
truncated helix constrained, peptides. In addition, a dimer
exchange experiment was performed for the most helical peptide
24. Spectra for a cJun-peptide solution and a cFos solution should,
upon mixing, generate an averaged spectrum if there was no dimer
exchange. However, helical spectra exceeded the average of the
two component spectra, indicating that dimer exchange did occur.
In contrast, for a cFos-peptide mixed with cJun, the average of the
two component spectra was observed, indicating that no change in
binding partner for peptide had occurred. Spectra for both
mixtures can be superimposed (Figure S4).
Thermodynamic Parameters for cFos Binding
To provide more insight to the origin of the binding affinity
(KD) between helix-constrained peptides and cFos, we decided to
dissect out the relative contributions of enthalpy versus entropy to
the affinities. Isothermal Titration Calorimetry (ITC) experiments
were conducted, enabling the free energy of binding to be split into
entropic and enthalpic components (Figure 5 and Table 1), while
also providing a stoichiometric measure of binding. Owing to the
relative stabilities of the interacting pairs, only complexes formed
between cFos and peptide 1, 2, 8, 10, 11, 12, 17, 20 and 22 and
24 were able to be characterised (see Table 1), with weaker
associations formed by 9 unable to be assessed. For these and other
pairs the thermodynamic parameters were unable to be deter-
mined by this technique owing to the large quantities of peptide
required in both the cell and the syringe.
Thermodynamic parameters determined from ITC measure-
ments on the above peptides indicate that the free energy of
binding is predominantly driven by a favourable enthalpic term
(DH 25.0 to 211.6 kcal/mol) with the entropic component either
favourable or weakly opposing (Table 1). The free energy of
binding for the longer parental JunWCANDI peptide is driven by an
even stronger enthalpic component (DH =214.8 kcal/mol) but
retarded by an unfavourable entropy term (TDS =26.9 kcal/
mol). This is precisely as expected from the increased conforma-
tional entropy in the denatured state, relative to the more ordered
helix-constrained peptides, that is lost upon binding to cFos [8].
Thus, truncation of the peptides has significantly reduced the
enthalpic contribution to DG, but this is in part compensated for
by a loss in the entropic barrier due to the helix-constraints. This is
consistent with the helix-constraints pre-organizing the peptides
into the receptor-binding conformation.
Structure and Stability of 24
2D proton NMR spectra were obtained for peptide 24. The
NOE summary diagram (Figure 2) reveals small 3JNHHa
coupling constants, low temperature coefficients Dd/T, and
many daN(i, i+3) NOEs which collectively indicate that peptide
24 is heavily populated with helical structures in water. Strong
daN(i,i+4) and daN(i,i+3), but only a few dab(i,i+2), NOEs reveal an
alpha-, rather than 310-, helical structure. A structure calcula-
tion using these NMR restraints produced a highly convergent
set of 20 lowest energy structures (RMSD = 1.87 A˚ over
backbone heavy atoms) without any violations in distance
restraints (.0.2 A˚) or dihedral angles (.5u). The NMR-derived
structures for peptide 24 are clearly in an alpha helical
conformation (Figure 2), with an averaged backbone RMSD
deviation from an idealized alpha helix of only 1.27 A˚.
However, the family of structures are somewhat flexible at the
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N- and C-terminal Cha residues. Figure 2 shows that thee three
iRi+4 helix constraints are located on a helix face away from
the face exposing the hydrophobic side chains (Cha1, I5, L8,
A12, L15, I19, Cha22) for interaction with Fos peptide in a
leucine zipper. This is consistent with the design intent to rigidly
constrain the hydrophobic residues at desired positions of the
heptad repeat for optimal exposure to cFos. Peptide 24 was also
fairly stable in human serum over 4 h at 37uC, whereas the
same sequences lacking the constraint were undetectable after 4
hours due to proteolytic cleavage (Figure 3).
Discussion
One, two, or three iRi+4 helix constraints have been
introduced into truncated peptide derived from a 37 residue
peptide sequence from cJun (JunWCANDI), itself a weak antagonist
of cJun binding to cFos. The aim was to investigate whether (a)
much shorter helix-constrained peptides could maintain high
affinity binding to cFos by virtue of pre-organizing the sequence in
a conformation ideal for interaction with cFos [42], (b) key side
chains in the Jun-based peptide represented sequence ‘‘hot spots’’
which were responsible for most of the energetic contributions to
binding with cFos, (c) enthalpy or entropy contributions were most
influential for binding, and (d) the downsized, helix-constrained,
peptides retained high specificity for cFos, competing with cJun.
Helix Induction
The use of iRi+4 helix-inducing constraints was successful in
producing highly alpha helical peptides, allowing truncation of the
sequence from 37 to 22 residues (but no shorter) without loss of
helicity. A constraint near the C-terminus of the peptides (heptads
3 and 4) was more effective in inducing helicity and enhancing
binding to cFos than a constraint introduced near the N-terminus
(heptads 1 and 2). It was found that although CD7 truncation
preserved some of the binding properties (8–9: Tm 32–38uC),
ND10 deletion peptides (10–24: Tm 44–52uC) were much
improved over ND14 deletions (5–7), suggesting a key role for
residues d2-g2. In addition to constraint insertion, other amino
acid substitutions were made to enhance core hydrophobic and
electrostatic contacts. The addition of non-natural Cha sidechains
to core residues within ND10 bicyclic peptides resulted in
stabilisation with cFos for replacement of the two outermost d
sidechains, suggesting that these act to constrain the helix to its
target while maintaining overall helicity. In arriving at 24 from
JunWCANDI over 40% of the molecule was removed while still
increasing overall helicity from 19 to 69%.
Figure 5. Isothermal Titration Calorimetry (ITC) analysis of leucine zipper domain interactions between constrained peptides and
cFos. Shown are isotherms for all ten measureable heterodimers (1, 2, 8, 10, 11, 12, 17, 20, 22, and 24) injected into a cell containinginto cFos. The top
and bottom panels show, respectively, raw data after baseline correction. During ITC experiments, approximately 200–600 mM of peptide A was
injected in 30–4065 ml batches from the injection syringe into the cell, which contained 10–40 mM cFos. Both partners were in a 10 mM Potassium
Phosphate buffer, 100 mM Potassium Fluoride at pH 7. Experiments were undertaken at 20uC. The solid lines represent the fit of the data to the
function based on the binding of a ligand to a macromolecule using the Microcal (GE Healthcare) Origin software [57].
doi:10.1371/journal.pone.0059415.g005
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Stability and Specificity
While constraining heptads 3 or 4 at the C-terminus was most
effective in promoting binding to cFos, truncating both heptads 1
and 2 did impact the binding suggesting that at least part of the
second heptad from the N-terminus is required for effective
binding. Subsequent designs incorporated residues d2-g2, since
the hydrophobic core appeared to be compromised if residue d2
was missing, and thus binding affinity is broadly distributed along
the length of the peptide from residues d2-d5 (Figure 6).
Qualitatively similar affinities were observed for all helix-
constrained peptides, regardless of the size of the molecule.
Importantly, all peptides capable of binding to cFos also retained
specificity in the presence of cJun that was displayed by the
CANDI-PCA selected parent peptide [42]. This was shown by
dimer exchange experiments and thermal melt comparisons of
equimolar solutions of peptide-cFos or peptide-cJun (Figures S2,
S3, S4). Finally, the most helical peptide by CD measurements was
24, which was examined by 2D-NMR spectroscopy and an alpha
helical structure was verified along its length (Figure 2). This
peptide was much more stable in human serum at 37u than the
same peptide lacking the constraints, due to a consequence of the
helix constraints and unnatural amino acids at each end (Figure 3).
Degradative proteolytic enzymes in serum are known to recognize
only denatured or extended strand peptide conformations in their
active sites, with helical structures being too large and protective of
peptide bonds to be cleaved by proteases [54,55]. In addition to
serum stability hydrocarbon restraints have additionally been
speculated to facilitate cell membrane permeability, with several
studies demonstrating this directly [7,15].
Thermodynamics
Consistent with a reduction in conformational freedom imposed
by the helix constraints, there is a measurable increase in the
entropic contribution to cFos binding. TDS was 26.9 kcal/mol
for cFos-JunWCANDI versus 23.8 to +1.6 kcal/mol for a cFos-
constrained peptide pair, with the triply bridged helical peptide 12
exhibiting a 7.5 kcal/mol more positive TDS than for JunWCANDI.
This contrasts with the weaker binding, but more helical, 24
where the Cha-Arg at the N-terminus and Cha at the C-terminus
appear to disfavour binding. Thus favourable free energy changes
on binding to cFos stem from a combination of enthalpic
contributions, reduced upon peptide truncation, and more
importantly, increased conformational entropy that arises from
introduction of the helix-inducing constraints. This contrasts with
the cFos-JunWCANDI interaction which was driven primarily by a
larger enthalpy than for the much shorter constrained peptides.
Because the coiled coil requires interactions along its entire length
for thermodynamic stability, truncation of the peptide causes a
large enough loss in enthalpy to compensate for the conforma-
tional entropy advantage that is conferred by the helix constraints.
Thus the extent of sequence truncation has been limited here to
splicing ,40% off the sequence and this balancing act, between
focussed entropic targeting of hot spots in a coiled coil (such as
helical heptads at the C-terminus in this case) and losing enthalpy
due to removal of many of the interactions that stabilize the coiled
coil [56], may be more difficult to achieve than for other helical
protein surfaces where there are more pronounced hot spots. In
particular for 24, hydrophobic residues d2, a3, d3, a4, d4, a5
and d5 (Cha, I, L, A L, I, Cha) are predicted to make large
enthalpic contributions to coiled-coil binding potency.
In summary, the affinity of cJun for cFos is dependent upon
interactions along the entire length of these two helical coils, with
the two C-terminal heptads contributing a little more enthalpy to
the interaction energy than the two N-terminal heptads. Thus,
Figure 6. Coiled coil structure of the cJun-cFos interaction.
Shown are the coiled coil regions of cJun (red) and cFos (blue)
interaction (PDB coordinates: 1FOS [58]). Side-chains for interfacial ‘a’
‘d’ ‘e’ and ‘g’ residues are shown and highlight the fact that the
interactions between them are distributed broadly across the molecule.
Key hydrophobic interfacial side-chains within cJun that are predicted
to be required for effective binding to cFos are shown in green (d2, a3,
d3, a4, d4, a5, d5, top to bottom: L, N, L, A, L, V, L).
doi:10.1371/journal.pone.0059415.g006
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shortening the sequence by over 40% from JunWCANDI to peptide
24 has correspondingly and proportionately reduced the free
energy and enthalpy of interaction, which has been compensated
for to some extent by pre-organizing the peptide in a stable alpha
helical conformation. This has led to peptides that bind to cFos in
the mM affinity range. In the future it may be possible to retain or
further improve the affinity of peptide interactions with cFos by
using further iterations of truncating the sequence, with alternative
positioning of helix-conferring constraints, such as these or others,
combined with non-natural amino acids, HBS approaches or the
use of b-peptides to generate even smaller peptidomimetics of AP-
1 components. However, the large surface area of interaction, the
shallow binding pockets, and especially the coiled coil nature of the
heterodimer make this and other transcription factors more
challenging than many other protein alpha helices to mimic using
smaller helix-constrained peptides. The extent to which helix-
constrained transcription factors can be shortened is uncertain but
this does represent a promising approach to generating smaller
transcriptional regulators. This research is particularly timely
given the rapid increase in knowledge from proteomics and
interactomics studies on transcriptional regulators in signalling
pathways.
Supporting Information
Figure S1 CD spectra for all constraints in this study.
These are shown both in isolation and as a mixture with cFos.
Data have been collected by measuring the level of helicity at
222 nm in an applied photophysics chirascan Circular Dichroism
(CD) Spectrometer. Data have been converted from raw ellipticity
to Molar Residue Ellipticity (MRE). From these raw data it is
possible to see which heterodimers constitute an increase over the
average of the homodimeric components (black dotted line). Any
increase in the helical signal that exceeds the average of cFos
(black) and the constrained peptide (blue), that would be
anticipated for a non-interacting pair, is clearly observed in the
heterodimeric profiles (red) and therefore strongly indicates the
presence of an interaction.
(TIFF)
Figure S2 Raw thermal melting data for homo and
heterodimeric complexes with cJun for constrained
peptides 1, 2, 8, 9, 10, 11, 12, 17, 20, 22, and 24. Shown
are raw thermal melting data for all homo and heterodimeric
complexes. Data have been collected by measuring the level of
helicity at 222 nm in an applied photophysics chirascan Circular
Dichroism (CD) Spectrometer. Data have been converted from
raw ellipticity to Molar Residue Ellipticity (MRE) according to
equation 1 to take account of the different peptide lengths.
Thermal melting data for cJun is shown in black, data for the
constrained peptide in isolation is shown in blue, the average of
these two as a black dotted line, with the cJun/constrained peptide
mixture is shown in red. It is clear that none of the peptides form a
stable interaction with cJun.
(TIFF)
Figure S3 CD spectra as MRE both in isolation and as a
mixture with cJun. From these raw data it is also clear that no
interaction is occurring between constrained peptides and cJun.
Rather, specta appear as averages of their homodimeric
components (i.e. superimpose with the homomeric averages). We
observe no heteromeric helical signal (red) that exceeds the
average (black dotted line) of cJun (black) and the constrained
peptide (blue), that would be anticipated for a non-interacting pair.
(TIFF)
Figure S4 Dimer exchange experiments between cJun,
cFos and constrained peptide 24. a) Equimolar mixures of
cJun-cJun and cFos-24 are mixed and the observed signal closely
resembles the average of the two constituent spectra, indicating no
change has occurred. b) Equimolar mixtures of cFos-cFos and
cJun-24 are mixed and the observed spectra greatly exceeds the
average of the two constituent spectra, indicating that dimer
exchange has occurred. c) Mixtures from a) and b) superimpose,
indicating that the same species is populated in both cases.
(TIFF)
Table S1 Helical Data obtained via Circular Dichroism.
Shown are A) homo and B) heteromeric samples. Column 1
displays the 222/208 ratio which can be used as an indication of
the presence of coiled coils. A ratio higher than 1 is generally
indicated evidence that a coiled coil has formed, while a ratio of
less than 0.9 is taken to indicate the presence of isolated helices.
Shown in column two are the calculated fractional helicities taken
from the Molar Residue Ellipticity at 22 nm. Fraction helicity (eH)
can be calculated as eH = (h2222hc)/(h222‘2hc) where
h222‘= (244000+250*T)*(12k/Nr) and hc = 2220–(53*T). In
these equations the wavelength dependent constant k = 2.4 (at
222 nm), Nr = the number of residues, and T = 20 degrees Celsius
(293 K). The 222/208 ratio is used to provide evidence on
whether the helices are monomeric or are adopting a quaternary
structure. Measured helicity for the original JunWCANDI peptide
and for the template on which the hydrocarbon constraints have
been introduced. These data take into account the constrained
variants which have been shown to introduce significant helicity
into the molecule. The N- and C-capping motifs have been
removed for the constrained since they are considered to be largely
redundant upon their introduction.
(DOC)
Table S2 Assigned 1H NMR signals for peptide 24 in
H2O:D2O (9:1) at 298 K.
(DOC)
File S1 Supporting Information.
(DOC)
Acknowledgments
The authors also wish to thank Dr Miao Yu for technical assistance.
Author Contributions
Conceived and designed the experiments: DPF JMM. Performed the
experiments: TR GRG TAH HNH. Analyzed the data: TR GRG TAH
DPF JMM. Contributed reagents/materials/analysis tools: TR GRG TAH
HNH DPF JMM. Wrote the paper: TR TAH DPF JMM.
References
1. Mason JM (2010) Design and development of peptides and peptide mimetics as
antagonists for therapeutic intervention. Future Med Chem 2: 1813–1822.
2. Fairlie DP, West ML, Wong AK (1998) Towards protein surface mimetics. Curr
Med Chem 5: 29–62.
3. Derossi D, Joliot AH, Chassaing G, Prochiantz A (1994) The third helix of the
Antennapedia homeodomain translocates through biological membranes. J Biol
Chem 269: 10444–10450.
4. Fuchs SM, Raines RT (2006) Internalization of cationic peptides: the road less
(or more?) traveled. Cell Mol Life Sci 63: 1819–1822.
Helix-Constrained cFos Peptides
PLOS ONE | www.plosone.org 11 March 2013 | Volume 8 | Issue 3 | e59415
5. Vives E, Brodin P, Lebleu B (1997) A truncated HIV-1 Tat protein basic
domain rapidly translocates through the plasma membrane and accumulates in
the cell nucleus. J Biol Chem 272: 16010–16017.
6. Judice JK, Tom JY, Huang W, Wrin T, Vennari J, et al. (1997) Inhibition of
HIV type 1 infectivity by constrained alpha-helical peptides: implications for the
viral fusion mechanism. Proc Natl Acad Sci U S A 94: 13426–13430.
7. Walensky LD, Kung AL, Escher I, Malia TJ, Barbuto S, et al. (2004) Activation
of apoptosis in vivo by a hydrocarbon-stapled BH3 helix. Science 305: 1466–
1470.
8. Kutchukian PS, Yang JS, Verdine GL, Shakhnovich EI (2009) All-atom model
for stabilization of alpha-helical structure in peptides by hydrocarbon staples.
J Am Chem Soc 131: 4622–4627.
9. Harrison RS, Shepherd NE, Hoang HN, Ruiz-Gomez G, Hill TA, et al. (2010)
Downsizing human, bacterial, and viral proteins to short water-stable alpha
helices that maintain biological potency. Proc Natl Acad Sci U S A 107: 11686–
11691.
10. Bird GH, Madani N, Perry AF, Princiotto AM, Supko JG, et al. (2010)
Hydrocarbon double-stapling remedies the proteolytic instability of a lengthy
peptide therapeutic. Proc Natl Acad Sci U S A 107: 14093–14098.
11. Shepherd NE, Hoang HN, Abbenante G, Fairlie DP (2005) Single turn peptide
alpha helices with exceptional stability in water. J Am Chem Soc 127: 2974–
2983.
12. Bernal F, Tyler AF, Korsmeyer SJ, Walensky LD, Verdine GL (2007)
Reactivation of the p53 tumor suppressor pathway by a stapled p53 peptide.
J Am Chem Soc 129: 2456–2457.
13. Walensky LD, Pitter K, Morash J, Oh KJ, Barbuto S, et al. (2006) A stapled BID
BH3 helix directly binds and activates BAX. Mol Cell 24: 199–210.
14. Bird GH, Bernal F, Pitter K, Walensky LD (2008) Synthesis and biophysical
characterization of stabilized alpha-helices of BCL-2 domains. Methods
Enzymol 446: 369–386.
15. Moellering RE, Cornejo M, Davis TN, Del Bianco C, Aster JC, et al. (2009)
Direct inhibition of the NOTCH transcription factor complex. Nature 462:
182–188.
16. Kim YW, Verdine GL (2009) Stereochemical effects of all-hydrocarbon tethers
in i,i+4 stapled peptides. Bioorg Med Chem Lett 19: 2533–2536.
17. Bernal F, Wade M, Godes M, Davis TN, Whitehead DG, et al. (2010) A stapled
p53 helix overcomes HDMX-mediated suppression of p53. Cancer Cell 18:
411–422.
18. Kim YW, Grossmann TN, Verdine GL (2011) Synthesis of all-hydrocarbon
stapled alpha-helical peptides by ring-closing olefin metathesis. Nat Protoc 6:
761–771.
19. Baek S, Kutchukian PS, Verdine GL, Huber R, Holak TA, et al. (2012)
Structure of the stapled p53 peptide bound to Mdm2. J Am Chem Soc 134:
103–106.
20. Chapman RN, Dimartino G, Arora PS (2004) A highly stable short alpha-helix
constrained by a main-chain hydrogen-bond surrogate. J Am Chem Soc 126:
12252–12253.
21. Wang D, Liao W, Arora PS (2005) Enhanced metabolic stability and protein-
binding properties of artificial alpha helices derived from a hydrogen-bond
surrogate: application to Bcl-xL. Angew Chem Int Ed Engl 44: 6525–6529.
22. Wang D, Chen K, Kulp Iii JL, Arora PS (2006) Evaluation of biologically
relevant short alpha-helices stabilized by a main-chain hydrogen-bond surrogate.
J Am Chem Soc 128: 9248–9256.
23. Wang D, Chen K, Dimartino G, Arora PS (2006) Nucleation and stability of
hydrogen-bond surrogate-based alpha-helices. Org Biomol Chem 4: 4074–4081.
24. Patgiri A, Jochim AL, Arora PS (2008) A hydrogen bond surrogate approach for
stabilization of short peptide sequences in alpha-helical conformation. Acc
Chem Res 41: 1289–1300.
25. Chapman R, Kulp JL 3rd, Patgiri A, Kallenbach NR, Bracken C, et al. (2008)
Trapping a folding intermediate of the alpha-helix: stabilization of the pi-helix.
Biochemistry 47: 4189–4195.
26. Liu J, Wang D, Zheng Q, Lu M, Arora PS (2008) Atomic structure of a short
alpha-helix stabilized by a main chain hydrogen-bond surrogate. J Am Chem
Soc 130: 4334–4337.
27. Wang D, Lu M, Arora PS (2008) Inhibition of HIV-1 fusion by hydrogen-bond-
surrogate-based alpha helices. Angew Chem Int Ed Engl 47: 1879–1882.
28. Henchey LK, Kushal S, Dubey R, Chapman RN, Olenyuk BZ, et al. (2010)
Inhibition of hypoxia inducible factor 1-transcription coactivator interaction by
a hydrogen bond surrogate alpha-helix. J Am Chem Soc 132: 941–943.
29. Guarracino DA, Bullock BN, Arora PS (2011) Mini review: protein-protein
interactions in transcription: a fertile ground for helix mimetics. Biopolymers 95:
1–7.
30. Bullock BN, Jochim AL, Arora PS (2011) Assessing helical protein interfaces for
inhibitor design. J Am Chem Soc 133: 14220–14223.
31. Appella DH, Christianson LA, Klein DA, Powell DR, Huang X, et al. (1997)
Residue-based control of helix shape in beta-peptide oligomers. Nature 387:
381–384.
32. Seebach D, Gardiner J (2008) Beta-peptidic peptidomimetics. Acc Chem Res 41:
1366–1375.
33. Shepherd NE, Abbenante G, Fairlie DP (2004) Consecutive cyclic pentapeptide
modules form short alpha-helices that are very stable to water and denaturants.
Angew Chem Int Ed Engl 43: 2687–2690.
34. Shepherd NE, Hoang HN, Desai VS, Letouze E, Young PR, et al. (2006)
Modular alpha-helical mimetics with antiviral activity against respiratory
syncitial virus. J Am Chem Soc 128: 13284–13289.
35. Pace CN, Grimsley GR, Thomson JA, Barnett BJ (1988) Conformational
stability and activity of ribonuclease T1 with zero, one, and two intact disulfide
bonds. J Biol Chem 263: 11820–11825.
36. Ozanne BW, Spence HJ, McGarry LC, Hennigan RF (2007) Transcription
factors control invasion: AP-1 the first among equals. Oncogene 26: 1–10.
37. Eferl R, Wagner EF (2003) AP-1: a double-edged sword in tumorigenesis. Nat
Rev Cancer 3: 859–868.
38. Libermann TA, Zerbini LF (2006) Targeting transcription factors for cancer
gene therapy. Curr Gene Ther 6: 17–33.
39. Zenz R, Eferl R, Scheinecker C, Redlich K, Smolen J, et al. (2008) Activator
protein 1 (Fos/Jun) functions in inflammatory bone and skin disease. Arthritis
Res Ther 10: 201.
40. Wagner EF, Eferl R (2005) Fos/AP-1 proteins in bone and the immune system.
Immunol Rev 208: 126–140.
41. Aud D, Peng SL (2006) Mechanisms of disease: Transcription factors in
inflammatory arthritis. Nat Clin Pract Rheumatol 2: 434–442.
42. Mason JM, Muller KM, Arndt KM (2007) Positive aspects of negative design:
simultaneous selection of specificity and interaction stability. Biochemistry 46:
4804–4814.
43. Lavigne P, Sonnichsen FD, Kay CM, Hodges RS (1996) Interhelical salt bridges,
coiled-coil stability, and specificity of dimerization. Science 271: 1136–1138.
44. O’Shea EK, Lumb KJ, Kim PS (1993) Peptide ‘Velcro’: design of a
heterodimeric coiled coil. Curr Biol 3: 658–667.
45. O’Shea EK, Rutkowski R, Kim PS (1989) Evidence that the leucine zipper is a
coiled coil. Science 243: 538–542.
46. O’Shea EK, Rutkowski R, Kim PS (1992) Mechanism of specificity in the Fos-
Jun oncoprotein heterodimer. Cell 68: 699–708.
47. Mason JM, Schmitz MA, Muller KM, Arndt KM (2006) Semirational design of
Jun-Fos coiled coils with increased affinity: Universal implications for leucine
zipper prediction and design. Proc Natl Acad Sci U S A 103: 8989–8994.
48. Mason JM, Hagemann UB, Arndt KM (2009) Role of hydrophobic and
electrostatic interactions in coiled coil stability and specificity. Biochemistry 48:
10380–10388.
49. Crooks RO, Rao T, Mason JM (2011) Truncation, Randomization, and
Selection: Generation of a Reduced Length c-Jun Antagonist That Retains High
Interaction Stability. J Biol Chem 286: 29470–29479.
50. Dixon JM, Taniguchi M, Lindsey JS (2005) PhotochemCAD 2: a refined
program with accompanying spectral databases for photochemical calculations.
Photochem Photobiol 81: 212–213.
51. Brooks BR, Bruccoleri RE, Olafson BD, States DJ, Swaminathan S, et al. (1983)
CHARMM: A program for macromolecular energy, minimization, and
dynamics calculations. J Comput Chem 4: 187–217.
52. Ibarra-Molero B, Makhatadze GI, Matthews CR (2001) Mapping the energy
surface for the folding reaction of the coiled-coil peptide GCN4-p1.
Biochemistry 40: 719–731.
53. Krylov D, Barchi J, Vinson C (1998) Inter-helical interactions in the leucine
zipper coiled coil dimer: pH and salt dependence of coupling energy between
charged amino acids. J Mol Biol 279: 959–972.
54. Fairlie DP, Tyndall JD, Reid RC, Wong AK, Abbenante G, et al. (2000)
Conformational selection of inhibitors and substrates by proteolytic enzymes:
implications for drug design and polypeptide processing. J Med Chem 43: 1271–
1281.
55. Tyndall JD, Nall T, Fairlie DP (2005) Proteases universally recognize beta
strands in their active sites. Chem Rev 105: 973–999.
56. Johnson LM, Horne WS, Gellman SH (2011) Broad distribution of energetically
important contacts across an extended protein interface. J Am Chem Soc 133:
10038–10041.
57. Wiseman T, Williston S, Brandts JF, Lin LN (1989) Rapid measurement of
binding constants and heats of binding using a new titration calorimeter. Anal
Biochem 179: 131–137.
58. Glover JN, Harrison SC (1995) Crystal structure of the heterodimeric bZIP
transcription factor c-Fos-c-Jun bound to DNA. Nature 373: 257–261.
Helix-Constrained cFos Peptides
PLOS ONE | www.plosone.org 12 March 2013 | Volume 8 | Issue 3 | e59415
